CoolDude 8 juin 17:32

@Vulpes vulpes

Vous oubliez la dernière Dinesh et al., Journal of the Association of Physicians of India (Peer Reviewed).

https://www.japi.org/x284d434/hydroxychloroquine-for-sars-cov2-prophylaxis-in-healthcare-workers-ndash-a-multicentric-cohort-study-assessing-effectiveness-and-safety

Prophylaxis study with 2,727 Indian healthcare workers, showing lower risk of COVID-19 cases with treatment, and increasingly lower risk for longer durations of HCQ prophylaxis.

Risk of COVID-19 case, 60.1% lower, RR 0.40, p < 0.001, treatment 247 of 617 (40.0%), control 611 of 1473 (41.5%), adjusted per study, odds ratio converted to relative risk, >=6 weeks, logistic regression.


Risk of COVID-19 case, 35.1% lower, RR 0.65, p < 0.001, treatment 88 of 185 (47.6%), control 611 of 1473 (41.5%), adjusted per study, odds ratio converted to relative risk, 4-5 weeks, logistic regression.


Risk of COVID-19 case, 23.2% lower, RR 0.77, p = 0.002, treatment 80 of 181 (44.2%), control 611 of 1473 (41.5%), adjusted per study, odds ratio converted to relative risk, 2-3 weeks, logistic regression.




Ajouter une réaction

Pour réagir, identifiez-vous avec votre login / mot de passe